Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Pulmonary Arterial Hypertension.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT06003244
What this trial is testing

High Altitude (HA) Residents With Pulmonary Vascular Diseases (PVD), 6 Minute Walk Distance (6MWD) Assessed at 2840m (HA) With and Without Supplemental Oxygen Therapy (SOT)

Who this might be right for
Pulmonary Vascular DiseasePulmonary Artery HypertensionChronic Thromboembolic Pulmonary Hypertension
University of Zurich 24
Not applicableUnknownNCT05641675
What this trial is testing

Non-invasive Pulmonary Artery Prediction (ADOPTS)

Who this might be right for
Heart FailurePulmonary Arterial Hypertension
Silverleaf Medical Sciences INC 25
Large-scale testing (Phase 3)Ended earlyNCT04811092
What this trial is testing

Study of Sotatercept in Newly Diagnosed Intermediate- and High-Risk PAH Participants (MK-7962-005/A011-13)

Who this might be right for
Pulmonary Arterial Hypertension
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 321
Early research (Phase 1)Looking for participantsNCT05967299
What this trial is testing

Study of Intravenous ZMA001 in Healthy Subjects

Who this might be right for
Pulmonary Arterial Hypertension PAH
National Heart, Lung, and Blood Institute (NHLBI) 96
Post-approval studies (Phase 4)Study completedNCT00433329
What this trial is testing

Combination Therapy in Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Actelion 100
Not applicableUnknownNCT03819777
What this trial is testing

Volatile Organic Compounds (VOCs) as a Biomarker in Immune-mediated Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial HypertensionSystemic SclerosisSystemic Lupus
Maastricht University Medical Center 150
Not applicableUnknownNCT05029167
What this trial is testing

REstrictive Versus LIberal Oxygen Strategy and Its Effect on Pulmonary Hypertension After Out-of-hospital Cardiac Arrest (RELIEPH-study)

Who this might be right for
Hypertension, Pulmonary ArterialOut-Of-Hospital Cardiac ArrestIntensive Care Unit+3 more
University of Southern Denmark 300
Not applicableStudy completedNCT02576002
What this trial is testing

Epidemiology and Treatment Patterns of Paediatric PAH (Pulmonary Arterial Hypertension)

Who this might be right for
Hypertension, Pulmonary
Bayer 2,691
Not applicableNot Yet RecruitingNCT07801846
What this trial is testing

Assessment of Heart Rate Variability HRV During Descent DE From 2850m to Sea Level and During Re-ascent A From Sea Level to 2850m in Healthy Individuals H

Who this might be right for
HealthyHealthy AdultHigh Altitude Effects+3 more
Silvia Ulrich Somaini 14
Early research (Phase 1)Study completedNCT03744637
What this trial is testing

Single Doses of Frespaciguat (MK-5475) on Pulmonary Vascular Resistance (MK-5475-002)

Who this might be right for
Pulmonary Arterial Hypertension
Merck Sharp & Dohme LLC 25
Early research (Phase 1)Study completedNCT00814645
What this trial is testing

Dose-Finding, Safety, Pharmacodynamic Effect Study of Sodium Nitrite Inhalation Solution in Normal, Healthy Volunteers

Who this might be right for
Pulmonary Arterial Hypertension
Aires Pharmaceuticals, Inc. 25
Post-approval studies (Phase 4)Ended earlyNCT02885012
What this trial is testing

Crossover Study From Macitentan or Bosentan Over to Ambrisentan

Who this might be right for
Pulmonary Arterial Hypertension
Medical University of South Carolina 3
Early research (Phase 1)Looking for participantsNCT06554301
What this trial is testing

A Study on the Efficacy and Safety of Empagliflozin in the Treatment of Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
China National Center for Cardiovascular Diseases 72
Not applicableUnknownNCT01907295
What this trial is testing

National Cohort Study of Idiopathic and Heritable Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
University of Cambridge 3,600
Large-scale testing (Phase 3)Ended earlyNCT03657095
What this trial is testing

A Study With BPS-314d-MR-PAH-303 in Participants With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Lung Biotechnology PBC 112
Post-approval studies (Phase 4)Looking for participantsNCT07140484
What this trial is testing

Sotatercept in Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Artery Hypertension
University of Alberta 27
Post-approval studies (Phase 4)Study completedNCT01305252
What this trial is testing

A 48-week Study of the Effect of Dual Therapy (Inhaled Treprostinil and Tadafafil) Versus Monotherapy (Tadalafil).

Who this might be right for
Hypertension, Pulmonary
Stanford University 21
Not applicableEnded earlyNCT02899533
What this trial is testing

[18F]FES PET/CT in PAH

Who this might be right for
Pulmonary Arterial Hypertension
University of Pennsylvania 5
Testing effectiveness (Phase 2)Study completedNCT01342952
What this trial is testing

Long-term Ambrisentan Extension Study for Pediatric Patients Who Participated in AMB112529

Who this might be right for
Hypertension, Pulmonary
GlaxoSmithKline 38
Not applicableStudy completedNCT03195959
What this trial is testing

Effect of Normobaric Hypoxia and Hyperoxia in Patients With Pulmonary Hypertension

Who this might be right for
Pulmonary Hypertension
University of Zurich 44
Next Page